Serlie M J, Struijk D G, de Blok K, Krediet R T
Department of Nephrology, University of Amsterdam, The Netherlands.
Adv Perit Dial. 1997;13:29-32.
Loss of transcapillary ultrafiltration (TCUF) can occur during continuous ambulatory peritoneal dialysis (CAPD) and may be caused by exposure to the high glucose concentrations in the dialysate, leading to glycation of water channels in the endothelial cells of the peritoneal microvessels. If this hypothesis is correct, diabetic patients should have lower TCUF rates at the onset of CAPD than nondiabetic controls. Such a difference should disappear during longer-duration CAPD because of the continuous glucose exposure in both groups, induced by the high glucose concentrations in the dialysate. Therefore, the standard peritoneal permeability analysis of 11 diabetic (mean age 48 years, range 33-70 years) and 11 nondiabetic patients (mean age 49 years, range 36-69 years) matched for sex, age, and duration of CAPD were studied shortly after the onset of CAPD treatment (mean duration 162 vs 131 days) and one year later. No differences were found in solute transport or protein clearances between the two groups at the onset of CAPD. The TCUF rate was lower in the diabetic patients: 0.9 mL/min (0.09-2.25) versus 1.51 mL/min (0.97-2.44), p = 0.01. The other parameters of fluid transport were not different. The mean osmotic pressure gradient, exerted by albumin and glucose, was 1.72 mmHg in the diabetic patients and 5.44 mmHg in the controls (p = 0.0004). No differences were found in peritoneal permeability, including TCUF, after one year between the two groups. In conclusion, the TCUF rate was lower in diabetic patients compared to nondiabetics only shortly after the onset of CAPD. These results suggest that long-term exposure to high glucose concentrations in diabetics prior to CAPD may cause changes in capillary wall aquaporins, similar to long-term exposure to high glucose concentrations in the dialysate in CAPD.
在持续性非卧床腹膜透析(CAPD)过程中可能会出现跨毛细血管超滤(TCUF)丧失,这可能是由于接触透析液中的高糖浓度所致,会导致腹膜微血管内皮细胞中水通道的糖基化。如果这一假设正确,糖尿病患者在开始CAPD时的TCUF率应低于非糖尿病对照组。由于两组在透析液高糖浓度诱导下持续接触葡萄糖,这种差异在较长时间的CAPD过程中应会消失。因此,对11例糖尿病患者(平均年龄48岁,范围33 - 70岁)和11例非糖尿病患者(平均年龄49岁,范围36 - 69岁)进行了标准腹膜通透性分析,这些患者在性别、年龄和CAPD持续时间上相匹配,研究时间为CAPD治疗开始后不久(平均持续时间分别为162天和131天)以及一年后。在CAPD开始时,两组之间的溶质转运或蛋白质清除率没有差异。糖尿病患者的TCUF率较低:0.9 mL/分钟(0.09 - 2.25),而非糖尿病患者为1.51 mL/分钟(0.97 - 2.44),p = 0.01。液体转运的其他参数没有差异。糖尿病患者中由白蛋白和葡萄糖产生的平均渗透压梯度为1.72 mmHg,对照组为5.44 mmHg(p = 0.0004)。两组在一年后腹膜通透性(包括TCUF)方面没有差异。总之,仅在CAPD开始后不久,糖尿病患者的TCUF率低于非糖尿病患者。这些结果表明,糖尿病患者在进行CAPD之前长期暴露于高糖浓度可能会导致毛细血管壁水通道蛋白发生变化,类似于CAPD中患者长期暴露于透析液中的高糖浓度。